Estimated Vaccination Coverage*,† with Selected Vaccines Among Adolescents 13-17 Years of Age§ by Poverty Level¶ and Race/Ethnicity** -- National Immunization Survey-Teen, United States, 2008
  Total
% (95% CI)
White only,
non-Hispanic
% (95% CI)
Black only,
non-Hispanic
% (95% CI)
Hispanic
% (95% CI)
American Indian or Alaska Native only,
non-Hispanic
% (95% CI)
Asian only,
non-Hispanic
% (95% CI)
>2 MMR††US National 89.3 (88.4-90.2)89.9 (88.8-90.8)89.1 (86.5-91.2)87.5 (84.4-90.0)93.9 (88.3-96.9)87.2 (77.3-93.1)
At or Above Poverty89.6 (88.6-90.6)89.7 (88.5-90.8)88.6 (84.9-91.5)90.4 (87.3-92.8)92.7 (85.1-96.5)86.6 (74.4-93.5)
Below Poverty87.1 (84.1-89.6)89.2 (86.0-91.7)89.1 (85.0-92.1)83.9 (77.5-88.8)95.2 (79.7-99.0)92.2 (73.7-98.0)
Unknown Poverty91.2 (87.4-93.9)93.3 (89.5-95.7)95.8 (89.3-98.4)86.4 (72.3-93.9)NANA
> 3 HepB§§US National 87.9 (86.9-88.8)88.1 (87.0-89.1)86.0 (83.3-88.3)89.8 (87.0-92.0)86.6 (77.6-92.4)89.9 (80.0-95.2)
At or Above Poverty88.0 (87.0-89.1)87.9 (86.7-89.0)85.8 (82.2-88.8)92.1 (89.3-94.3)88.3 (79.6-93.6)89.4 (77.0-95.5)
Below Poverty86.7 (83.9-89.1)88.4 (85.1-91.0)86.9 (82.3-90.4)86.2 (80.3-90.6)80.4 (55.1-93.2)93.2 (79.4-98.0)
Unknown Poverty89.8 (85.7-92.9)90.9 (84.9-94.7)82.9 (67.1-92.1)92.4 (85.8-96.1)NANA
> 1 Var¶¶US National 81.9 (80.2-83.6)82.8 (81.0-84.5)74.0 (68.4-78.9)84.5 (79.0-88.8)83.5 (68.4-92.2)89.1 (82.0-93.6)
At or Above Poverty82.9 (81.2-84.5)82.9 (80.9-84.7)74.8 (68.1-80.6)88.9 (84.5-92.2)92.2 (80.4-97.2)88.1 (79.2-93.6)
Below Poverty77.0 (71.1-82.1)74.4 (66.4-81.1)72.7 (61.5-81.7)80.0 (68.9-87.8)NANA
Unknown Poverty87.5 (82.1-91.5)90.5 (83.8-94.6)72.4 (52.7-86.0)85.1 (69.1-93.6)NANA
> 1 Td or Tdap***US National 72.2 (70.8-73.4)71.6 (70.1-73.0)71.4 (67.6-74.9)74.1 (70.0-77.8)81.4 (72.6-87.8)76.9 (67.2-84.4)
At or Above Poverty72.7 (71.3-74.1)72.3 (70.8-73.8)71.9 (67.0-76.2)75.7 (70.9-80.0)76.8 (64.8-85.6)76.6 (64.8-85.3)
Below Poverty70.9 (67.0-74.4)64.5 (59.3-69.3)68.9 (61.8-75.3)74.8 (67.7-80.8)87.4 (72.8-94.8)68.4 (45.5-84.8)
Unknown Poverty68.3 (60.2-75.5)67.5 (57.3-76.3)82.7 (69.9-90.8)57.7 (37.9-75.3)NANA
> 1 Tdap†††US National 40.8 (39.3-42.2)41.7 (40.1-43.3)36.0 (31.9-40.2)41.9 (37.5-46.5)43.5 (31.7-56.1)44.4 (34.4-54.9)
At or Above Poverty41.2 (39.7-42.8)42.5 (40.8-44.1)33.4 (29.2-37.9)44.0 (38.5-49.7)40.2 (27.1-55.0)42.3 (31.0-54.6)
Below Poverty38.6 (34.2-43.2)32.8 (28.0-38.0)39.0 (30.8-47.9)40.4 (32.6-48.7)51.1 (27.3-74.4)NA
Unknown Poverty41.1 (34.6-48.0)39.9 (32.0-48.3)50.1 (30.8-69.4)34.9 (22.2-50.3)NANA
> 1 MCV4§§§US National 41.8 (40.3-43.2)39.7 (38.2-41.2)43.1 (39.0-47.3)46.8 (42.2-51.4)47.3 (35.4-59.5)50.5 (40.3-60.8)
At or Above Poverty42.0 (40.5-43.5)40.3 (38.7-41.9)44.7 (39.7-49.8)48.9 (43.3-54.5)41.3 (28.1-55.8)49.2 (37.4-61.1)
Below Poverty40.8 (36.6-45.2)32.8 (28.0-37.9)38.8 (31.9-46.2)45.0 (37.1-53.2)62.6 (39.5-81.1)NA
Unknown Poverty40.9 (34.5-47.6)37.3 (30.3-44.9)50.5 (31.2-69.6)41.0 (25.7-58.3)NANA
> 1 HPV4¶¶¶US National 37.2 (35.1-39.3)35.0 (32.9-37.2)35.7 (29.6-42.4)44.4 (38.0-50.9)52.8 (35.4-69.6)40.6 (27.6-55.2)
At or Above Poverty35.8 (33.7-37.9)35.7 (33.5-38.0)31.2 (25.3-37.8)39.3 (31.7-47.4)51.3 (30.8-71.3)41.6 (26.5-58.6)
Below Poverty46.4 (39.8-53.1)33.6 (27.0-40.8)45.9 (32.0-60.4)53.0 (41.9-63.9)54.5 (24.8-81.3)NA
Unknown Poverty31.1 (23.5-39.9)25.2 (17.3-35.1)NANANANA

 
* Estimate presented as point estimate (%) ± 95% confidence interval (CI). Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.6.
† Estimate may be unreliable; (CI width)>20.
§ Adolescents in the 2008 NIS-Teen were born during January 1990 - February 1996. Vaccination coverage estimates include only adolescents who had adequately complete provider-reported immunization records.
¶ Based on family income and household size using US Bureau of Census poverty thresholds for 2007.
** Reported by respondent. Adolescents identified as White, Black, American Indian/Alaska Native, Asian, or Native Hawaiian/Pacific Islander are all non-Hispanic. Adolescents of Hispanic ethnicity may be of any race. Reported by respondent.
†† Includes > 2 doses of measles-mumps-rubella vaccine
§§ Includes > 3 doses of hepatitis B vaccine.
¶¶ Includes > 1 dose of varicella vaccine among adolescents without a history of varicella disease.
*** Includes > 1 dose of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.
††† Includes > 1 dose tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.
§§§ Includes percentages receiving meningococcal conjugate vaccine (MCV4) and meningococcal -unknown type vaccine.
¶¶¶ Quadrivalent human papillomavirus vaccine. Percentages reported among females only since HPV4 vaccine is only recommended for females.
tab16_race_pov2